(Q35746572)

10 August 2017

1 reference

title

Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations (English)

1 reference

10 August 2017

1 reference

Catherine C Crone

1

1 reference

10 August 2017

Geoffrey M Gabriel

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Clinical Pharmacokinetics

10 August 2017

published in

1 reference

10 August 2017

volume

43

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

361-394

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200443060-00002

10 August 2017

exact match

0 references

cites work

Methylphenidate in post liver transplant patients.

1 reference

12 December 2020

Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Drug disposition in cystic fibrosis

1 reference

12 December 2020

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

12 December 2020

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies

1 reference

12 December 2020

A depressed myocardium

1 reference

12 December 2020

Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.

1 reference

12 December 2020

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

12 December 2020

Buspirone: future directions

1 reference

12 December 2020

Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis

1 reference

12 December 2020

Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint

1 reference

12 December 2020

Pharmacokinetics of methylphenidate in man, rat and monkey

1 reference

12 December 2020

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity

1 reference

12 December 2020

Pemoline and hepatotoxicity

1 reference

12 December 2020

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis

1 reference

12 December 2020

Effects of liver disease on pharmacokinetics. An update

1 reference

12 December 2020

Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.

1 reference

12 December 2020

Human cytochromes mediating N-demethylation of fluoxetine in vitro

1 reference

12 December 2020

Antiarrhythmic agents: drug interactions of clinical significance

1 reference

12 December 2020

The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.

1 reference

12 December 2020

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

12 December 2020

Pharmacokinetics in patients with renal failure

1 reference

12 December 2020

Cardiovascular effects of bupropion in depressed patients with heart disease.

1 reference

12 December 2020

Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study

1 reference

12 December 2020

Absence of a sertraline-mediated effect on digoxin pharmacokinetics and electrocardiographic findings

1 reference

12 December 2020

Bupropion in depression. II. The role of metabolites in clinical outcome

1 reference

12 December 2020

Renal Impairment as a Possible Side Effect of Gabapentin

1 reference

12 December 2020

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

12 December 2020

Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine

1 reference

12 December 2020

Review of the animal pharmacology and pharmacokinetics of fluvoxamine

1 reference

12 December 2020

Conduction disturbances associated with venlafaxine

1 reference

12 December 2020

The effect of sertraline on the pharmacokinetics of desipramine and imipramine

1 reference

12 December 2020

Apparent interaction between nefazodone and cyclosporine

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

1 reference

12 December 2020

Clinical pharmacokinetics of bupropion: a review

1 reference

12 December 2020

Monoamine oxidase inhibitors. A perspective on their use in the elderly

1 reference

12 December 2020

Psychiatric aspects of lung transplant. The Toronto Lung Transplant Group.

1 reference

12 December 2020

Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy

1 reference

12 December 2020

Antidepressant profile of bupropion and three metabolites in mice

1 reference

12 December 2020

Drug pharmacokinetics in cardiac and hepatic disease

1 reference

12 December 2020

Monoamine oxidase inhibitors. An update on drug interactions

1 reference

12 December 2020

Metabolism of amitriptyline in patients with chronic renal failure

1 reference

12 December 2020

Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease.

1 reference

12 December 2020

Bruising associated with the use of fluoxetine

1 reference

12 December 2020

Psychopharmacologic treatment of depression in the medically ill

1 reference

12 December 2020

Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans

1 reference

12 December 2020

Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders

1 reference

12 December 2020

The kinetics of citalopram: single and multiple dose studies in man

1 reference

12 December 2020

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

12 December 2020

The response of the breathless patient treated with diazepam.

1 reference

12 December 2020

Lack of citalopram effect on the pharmacokinetics of cyclosporine

1 reference

12 December 2020

Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources

1 reference

12 December 2020

The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients

1 reference

12 December 2020

Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation

1 reference

12 December 2020

Pharmacokinetics of monoamine oxidase inhibitors

1 reference

12 December 2020

Nefazodone in patients with treatment-refractory posttraumatic stress disorder

1 reference

12 December 2020

Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment

1 reference

12 December 2020

Clinical pharmacokinetics of mirtazapine

1 reference

12 December 2020

Nefazodone-induced liver failure: report of three cases

1 reference

12 December 2020

Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers

1 reference

12 December 2020

Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

12 December 2020

Venlafaxine: A Structurally Unique and Novel Antidepressant

1 reference

12 December 2020

Pharmacotherapy for post-traumatic stress disorder: a comprehensive review

1 reference

12 December 2020

An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder

1 reference

12 December 2020

Pilot open-label study of nefazodone in panic disorder.

1 reference

12 December 2020

Bupropion plasma levels and CYP2D6 phenotype

1 reference

12 December 2020

Drug dosing in renal insufficiency.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects

1 reference

12 December 2020

The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin

1 reference

12 December 2020

Use of psychostimulants in medically ill depressed patients

1 reference

12 December 2020

Mirtazapine versus fluoxetine in the treatment of panic disorder

1 reference

12 December 2020

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

1 reference

12 December 2020

A pilot study of mirtazapine in post-traumatic stress disorder

1 reference

12 December 2020

Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Clinical pharmacokinetics in heart failure. An updated review

1 reference

12 December 2020

Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem

1 reference

12 December 2020

Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors.

1 reference

12 December 2020

Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed?

1 reference

12 December 2020

The clinical relevance of preclinical data: mirtazapine, a model compound

1 reference

12 December 2020

Single dose pharmacokinetics of trazodone in healthy subjects

1 reference

12 December 2020

Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.

1 reference

12 December 2020

Effects of aging and liver disease on disposition of lorazepam

1 reference

12 December 2020

Pharmacokinetics of rapamycin

1 reference

12 December 2020

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

1 reference

12 December 2020

Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients

1 reference

12 December 2020

Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

1 reference

12 December 2020

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

1 reference

12 December 2020

Acute liver failure after treatment with nefazodone

1 reference

12 December 2020

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

1 reference

12 December 2020

Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease?

1 reference

12 December 2020

Effect of fluoxetine on prothrombin time

1 reference

12 December 2020

Drug metabolism in patients with liver disease

1 reference

12 December 2020

Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

1 reference

12 December 2020

Gabapentin as a potential treatment for anxiety disorders.

1 reference

12 December 2020

Bupropion slow-release response in depression: diagnosis and biochemistry

1 reference

12 December 2020

Escitalopram: superior to citalopram or a chiral chimera?

1 reference

12 December 2020

Cardiovascular safety in depressed patients: focus on venlafaxine

1 reference

12 December 2020

Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions

1 reference

12 December 2020

Cyclosporine-drug interactions and the influence of patient age

1 reference

12 December 2020

Recognition and treatment of posttraumatic stress disorder

1 reference

12 December 2020

Prolonged sedation due to accumulation of conjugated metabolites of midazolam

1 reference

12 December 2020

Pharmacology and pharmacokinetics of citalopram and other SSRIs.

1 reference

12 December 2020

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan

1 reference

12 December 2020

Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression

1 reference

12 December 2020

Depression in the medically ill. Critical issues in diagnostic assessment.

1 reference

12 December 2020

Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses

1 reference

12 December 2020

Clinical pharmacokinetics of fluoxetine

1 reference

12 December 2020

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

1 reference

12 December 2020

1 reference

12 December 2020

Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders.

1 reference

12 December 2020

Nefazodone: preclinical pharmacology of a new antidepressant

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly

1 reference

12 December 2020

Psychopharmacology in patients with renal failure

1 reference

12 December 2020

Efficacy of open-label nefazodone treatment in patients with panic disorder.

1 reference

12 December 2020

Buspirone for the treatment of anxiety in patients with chronic obstructive airways disease

1 reference

12 December 2020

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

12 December 2020

Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4

1 reference

12 December 2020

Fluoxetine disposition and elimination in cirrhosis

1 reference

12 December 2020

Trazodone and hemodialysis

1 reference

12 December 2020

Effect of hepatic insufficiency on pharmacokinetics and drug dosing

1 reference

12 December 2020

Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.

1 reference

12 December 2020

Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.

1 reference

12 December 2020

Clinical Pharmacokinetics of Oral Buspirone in Patients with Impaired Renal Function

1 reference

12 December 2020

Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation.

1 reference

12 December 2020

Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.

1 reference

12 December 2020

Pharmacokinetics in patients with cardiac failure

1 reference

12 December 2020

Influence of liver cirrhosis on sertraline pharmacokinetics.

1 reference

12 December 2020

Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.

1 reference

12 December 2020

Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.

1 reference

12 December 2020

An open trial of nefazodone in adult patients with generalized anxiety disorder

1 reference

12 December 2020

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

1 reference

12 December 2020

Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.

1 reference

12 December 2020

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

12 December 2020

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1 reference

12 December 2020

Treatment of generalized anxiety disorder.

1 reference

12 December 2020

The pharmacokinetics of paroxetine in patients with liver cirrhosis

1 reference

12 December 2020

Depression in hemodialysis patients

1 reference

12 December 2020

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

12 December 2020

Post-traumatic stress disorder

1 reference

12 December 2020

Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine

1 reference

12 December 2020

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

1 reference

12 December 2020

Reversible nefazodone-induced liver failure

1 reference

12 December 2020

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial

1 reference

12 December 2020

Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy.

1 reference

12 December 2020

Tricyclic antidepressant and metabolite levels in chronic renal failure

1 reference

12 December 2020

Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

Influence of acute renal failure on FPIA rapid serum assay of midazolam and its main metabolite.

1 reference

12 December 2020

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

12 December 2020

Venlafaxine-associated hepatitis

1 reference

12 December 2020

Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro

1 reference

12 December 2020

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Gabapentin treatment for posttraumatic stress disorder

1 reference

12 December 2020

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Drug administration in chronic liver disease

1 reference

12 December 2020

Interaction between tacrolimus and nefazodone in a stable renal transplant recipient

1 reference

12 December 2020

Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy

1 reference

12 December 2020

Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients.

1 reference

12 December 2020

Effect of diazepam on sleep in patients with chronic airflow obstruction

1 reference

12 December 2020

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

1 reference

12 December 2020

Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment

1 reference

12 December 2020

Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders

1 reference

12 December 2020

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

1 reference

12 December 2020

Use of stimulants in the medically ill.

1 reference

12 December 2020

Reversible acute renal allograft dysfunction due to gabapentin.

1 reference

12 December 2020

Nonenteral routes of administration for psychiatric medications. A literature review

1 reference

12 December 2020

Selective serotonin-reuptake inhibitors: an update

1 reference

12 December 2020

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

1 reference

12 December 2020

The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone

1 reference

12 December 2020

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Prolonged bleeding time in a patient treated with sertraline

1 reference

12 December 2020

Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers

1 reference

12 December 2020

Inhibition of trazodone metabolism by thioridazine in humans

1 reference

12 December 2020

Does mirtazapine have a more rapid onset than SSRIs?

1 reference

12 December 2020

Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram

1 reference

12 December 2020

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

1 reference

12 December 2020

Trazodone overdose: four years of experience from voluntary reports

1 reference

12 December 2020

Escitalopram : a review of its use in the management of major depressive and anxiety disorders

1 reference

12 December 2020

Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics in critically ill patients

1 reference

12 December 2020

Clinical pharmacokinetics of lorazepam: a review

1 reference

12 December 2020

The effect of citalopram in panic disorder

1 reference

12 December 2020

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

12 December 2020

Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent

1 reference

12 December 2020

Effect of venlafaxine on the pharmacokinetics of risperidone.

1 reference

12 December 2020

Mirtazapine in major depression with comorbid generalized anxiety disorder

1 reference

12 December 2020

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

Psychiatric aspects of transplantation, II: Preoperative issues.

1 reference

12 December 2020

The effect of renal disease on the disposition of venlafaxine

1 reference

12 December 2020

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline

1 reference

12 December 2020

Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study

1 reference

12 December 2020

Nefazodone and cyclosporine drug-drug interaction

1 reference

12 December 2020

Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal.

1 reference

12 December 2020

Pemoline hepatotoxicity and postmarketing surveillance

1 reference

12 December 2020

The pharmacokinetics of nortriptyline in patients with chronic renal failure

1 reference

12 December 2020

Interaction between warfarin and trazodone

1 reference

12 December 2020

Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo

1 reference

12 December 2020

Modafinil: a gift to portmanteau

1 reference

12 December 2020

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease

1 reference

12 December 2020

Psychiatric morbidity in patients undergoing heart, heart and lung, or lung transplantation.

1 reference

12 December 2020

Buspirone for anxiety disorders in patients with severe lung disease

1 reference

12 December 2020

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.

1 reference

12 December 2020

Venlafaxine-associated hepatitis

1 reference

12 December 2020

Low-dose venlafaxine treatment in panic disorder

1 reference

12 December 2020

Pemoline-associated hepatic failure: a critical analysis of the literature

1 reference

12 December 2020

Pharmacological treatment of anxiety in the medically ill patient

1 reference

12 December 2020

Psychiatric aspects of transplantation, III: Postoperative issues

1 reference

12 December 2020

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

12 December 2020

Disease-induced modifications of drug pharmacokinetics.

1 reference

12 December 2020

Trazodone in the treatment of panic disorder and agoraphobia with panic attacks

1 reference

12 December 2020

Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram

1 reference

12 December 2020

Prescribing in liver disease

1 reference

12 December 2020

Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration

1 reference

12 December 2020

Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers

1 reference

12 December 2020

QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination

1 reference

12 December 2020

Pharmacokinetics of second generation antidepressants: bupropion

1 reference

12 December 2020

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

1 reference

12 December 2020

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

12 December 2020

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

A prospective trial of modafinil as an adjunctive treatment of major depression

1 reference

12 December 2020

Treatment of generalized anxiety disorder with citalopram

1 reference

12 December 2020

Hemodialyzability of sertraline

1 reference

12 December 2020

Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.

1 reference

12 December 2020

Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity.

1 reference

12 December 2020

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

12 December 2020

Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone

1 reference

12 December 2020

Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.

1 reference

12 December 2020

Pharmacokinetics of the newer benzodiazepines

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients

1 reference

12 December 2020

Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy

1 reference

12 December 2020

CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

1 reference

12 December 2020

Venlafaxine oxidation in vitro is catalysed by CYP2D6.

1 reference

12 December 2020

Non-linear fluvoxamine disposition

1 reference

12 December 2020

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

12 December 2020

Nephrology: 3. Safe drug prescribing for patients with renal insufficiency

1 reference

12 December 2020

Reduction of prothrombin and partial thromboplastin times with trazodone

1 reference

12 December 2020

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.

1 reference

12 December 2020

Cardiovascular and neurological toxicity of venlafaxine

1 reference

12 December 2020

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

12 December 2020

Pharmacokinetics in liver disease

1 reference

12 December 2020

Drug elimination in chronic liver diseases

1 reference

12 December 2020

Buspirone pharmacokinetics in patients with cirrhosis

1 reference

12 December 2020

Effects of Estazolam and Flurazepam on Cardiopulmonary Function in Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Bupropion treatment in veterans with posttraumatic stress disorder: an open study

1 reference

12 December 2020

Fluvoxamine maleate: metabolism in man

1 reference

12 December 2020

PTSD in heart transplant recipients and their primary family caregivers

1 reference

12 December 2020

Lack of antidepressant-cyclosporine pharmacokinetic interactions

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

12 December 2020

Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma

1 reference

12 December 2020

Drug-drug interactions involving antidepressants: focus on venlafaxine

1 reference

12 December 2020

Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. French University Antidepressant Group

1 reference

12 December 2020

Overview of the pharmacokinetics of fluvoxamine

1 reference

12 December 2020

Interactions between cyclosporine and newer antidepressant medications

1 reference

12 December 2020

The pharmacokinetics of paroxetine in renal impairment

1 reference

12 December 2020

Psychostimulant treatment of depressive disorders secondary to medical illness

1 reference

12 December 2020

Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

12 December 2020

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses

1 reference

12 December 2020

Venlafaxine extended-release: a review of its use in the management of major depression

1 reference

12 December 2020

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

12 December 2020

Metabolism of monoamine oxidase inhibitors

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update

1 reference

12 December 2020

Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects

1 reference

12 December 2020

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans

1 reference

12 December 2020

Pharmacokinetics of paroxetine in patients with cirrhosis

1 reference

12 December 2020

1 reference

12 December 2020

Sertraline does not alter the beta-adrenergic blocking activity of atenolol in healthy male volunteers

1 reference

12 December 2020

Influence of anxiolytic drugs (Prazepam and Diazepam) on respiratory center output and CO2 chemosensitivity in patients with lung diseases.

1 reference

12 December 2020

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

12 December 2020

Clinical Implications of the Pharmacology of Sertraline

1 reference

12 December 2020

Normal disposition of oxazepam in acute viral hepatitis and cirrhosis

1 reference

12 December 2020

Metabolism of tricyclic antidepressants

1 reference

12 December 2020

Monoamine Oxidase Inhibitors

1 reference

12 December 2020

10.2165/00003088-200443060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1030356996

0 references

1 reference